Darin Taverna

2.0k total citations
21 papers, 672 citations indexed

About

Darin Taverna is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Darin Taverna has authored 21 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Cell Biology. Recurrent topics in Darin Taverna's work include Proteoglycans and glycosaminoglycans research (7 papers), Protein Structure and Dynamics (4 papers) and Fibroblast Growth Factor Research (3 papers). Darin Taverna is often cited by papers focused on Proteoglycans and glycosaminoglycans research (7 papers), Protein Structure and Dynamics (4 papers) and Fibroblast Growth Factor Research (3 papers). Darin Taverna collaborates with scholars based in United States, Denmark and Germany. Darin Taverna's co-authors include Richard A. Goldstein, Johanna K. DiStefano, Michael J. LaBarre, Daniel D. Von Hoff, Barbara Blouw, H. Michael Shepard, Haiyong Han, Clifford J. Whatcott, Nicholas Willumsen and Curtis B. Thompson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Darin Taverna

19 papers receiving 656 citations

Peers

Countries citing papers authored by Darin Taverna

Since Specialization

Citations

This map shows the geographic impact of Darin Taverna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darin Taverna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darin Taverna more than expected).

Fields of papers citing papers by Darin Taverna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darin Taverna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darin Taverna. The network helps show where Darin Taverna may publish in the future.

Co-authorship network of co-authors of Darin Taverna

This figure shows the co-authorship network connecting the top 25 collaborators of Darin Taverna. A scholar is included among the top collaborators of Darin Taverna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darin Taverna. Darin Taverna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa 2021 ·Journal of Translational Medicine ·Song Wang, Cecilie L. Bager, M.A. Karsdal, Dimitrios Chondros, Darin Taverna, Nicholas Willumsen	17
2	GJB5 association with BRAF mutation and survival in cutaneous malignant melanoma 2021 ·British Journal of Dermatology ·Maria Scatolini, Ankit Patel, Enrico Grosso, Maurizia Mello‐Grand, Paola Ostano, (unknown), Marianna Vitiello, Tiziana Venesio, Alessandro Zaccagna, Alberto Pisacane, Ivana Sarotto, Darin Taverna, Laura Poliseno, Daniele Bergamaschi, Giovanna Chiorino	9
3	Use of computed tomography to assess subcutaneous drug dispersion with recombinant human hyaluronidase PH20 in a swine model 2020 ·Journal of Pharmacological and Toxicological Methods ·Robert Connor, Darin Taverna, Karla D. Thrall, Michael J. LaBarre, David W. Kang	8
4	Hyaluronan (HA) accumulation in the tumor microenvironment (TME) is increased in colorectal cancer (CRC) and associated with consensus molecular subtypes (CMS) 4 molecular subtype 2019 ·Annals of Oncology ·Barbara Blouw, Lisa Ryner, (unknown), Darin Taverna, (unknown)	1
5	Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression 2018 ·Clinical Cancer Research ·Xiaoming Li, H. Michael Shepard, (unknown), Chun‐Mei Zhao, Ryan J. Osgood, Sanna Rosengren, Barbara Blouw, (unknown), Mark D. Pagel, Clifford J. Whatcott, Haiyong Han, Daniel D. Von Hoff, Darin Taverna, Michael J. LaBarre, Daniel C. Maneval, Curtis B. Thompson	69
6	Abstract 1743: Rationale for evaluating PEGylated recombinant human hyaluronidase PH20 (pegvorhyaluronidase alfa; PEGPH20) in patients with hyaluronan (HA)-accumulating colorectal cancer 2018 ·Cancer Research ·(unknown), Benjamin J. Thompson, Darin Taverna, Barbara Blouw, Ji Sook Lee, Curtis B. Thompson, Daniel C. Maneval	1
7	PO-262 Remodelling of the tumour microenvironment by pegvorhyalurondiase alfa (PEGPH20): a novel, first-in-class biologic that enzymatically degrades tumour hyaluronan (HA) to improve anti-tumour efficacy 2018 ·ESMO Open ·Benjamin J. Thompson, (unknown), (unknown), Darin Taverna, (unknown), Barbara Blouw, (unknown), Curtis B. Thompson, Daniel C. Maneval	0
8	Extracellular matrix (ECM) circulating peptide biomarkers as potential predictors of survival in patients (pts) with untreated metastatic pancreatic ductal adenocarcinoma (mPDA) receiving pegvorhyaluronidase alfa (PEGPH20), nab-paclitaxel (A), and gemcitabine (G). 2018 ·Journal of Clinical Oncology ·Song Wang, Nicholas Willumsen, Cecilie L. Bager, M.A. Karsdal, Dimitrios Chondros, Darin Taverna	6
9	Fine-Mapping IGF1 and Prostate Cancer Risk in African Americans: The Multiethnic Cohort Study 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Elena Giorgi, Daniel O. Stram, Darin Taverna, Stephen Turner, Fredrick R. Schumacher, Christopher A. Haiman, Annette Lum‐Jones, (unknown), Christian Caberto, David Duggan, Brian E. Henderson, Loı̈c Le Marchand, Iona Cheng	7
10	Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia 2013 ·Genes Chromosomes and Cancer ·Sarah E. Kleinstein, Laura Heath, Karen W. Makar, Elizabeth M. Poole, (unknown), Martha L. Slattery, Liren Xiao, David Duggan, Li Hsu, Karen Curtin, Lisel Koepl, Jill Muehling, Darin Taverna, Bette J. Caan, Christopher S. Carlson, John D. Potter, Cornelia M. Ulrich	32
11	Genetic Variation in the Inflammation and Innate Immunity Pathways and Colorectal Cancer Risk 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Hansong Wang, Darin Taverna, Daniel O. Stram, Barbara K. Fortini, Iona Cheng, Lynne R. Wilkens, Terrilea Burnett, Karen W. Makar, Noralane M. Lindor, John L. Hopper, Steve Gallinger, John A. Baron, Robert W. Haile, Laurence N. Kolonel, Brian E. Henderson, Polly A. Newcomb, Graham Casey, David Duggan, Cornelia M. Ulrich, Loı̈c Le Marchand	14
12	Technological Issues and Experimental Design of Gene Association Studies 2010 ·Methods in molecular biology ·Johanna K. DiStefano, Darin Taverna	15
13	Genome wide survey of microRNA-Transcription Factor regulatory circuits in human 2009 ·Molecular BioSystems ·(unknown), Davide Corà, Darin Taverna, Michele Caselle	4
14	Molecular profiling using immunohistochemistry (IHC) and DNA microarray (DMA) as a tool to determine potential therapeutic targets in patients who have progressed on multiple prior therapies 2006 ·Clinical Cancer Research ·Mitesh J. Borad, Robert Penny, Michael Bittner, Johanna Gardner, S Shack, Elizabeth Campbell, Darin Taverna, Richard R. Love, Jeffrey M. Trent, Daniel D. Von Hoff	4
15	Frequency of potential therapeutic targets identified by immunohistochemistry (IHC) and DNA microarray (DMA) in tumors from patients who have progressed on multiple therapeutic agents 2006 ·Journal of Clinical Oncology ·Daniel D. Von Hoff, Robert Penny, S Shack, Elizabeth Campbell, Darin Taverna, Mitesh J. Borad, Daria N. Love, Jeffrey M. Trent, Michael Bittner	15
16	Why are proteins so robust to site mutations? 2002 ·Journal of Molecular Biology ·Darin Taverna, Richard A. Goldstein	120
17	Why are proteins marginally stable? 2001 ·Proteins Structure Function and Bioinformatics ·Darin Taverna, Richard A. Goldstein	281
18	The distribution of structures in evolving protein populations 2000 ·Biopolymers ·Darin Taverna, Richard A. Goldstein	57
19	The distribution of structures in evolving protein populations 2000 ·Biopolymers ·Darin Taverna, Richard A. Goldstein	0
20	THE EVOLUTION OF DUPLICATED GENES CONSIDERING PROTEIN STABILITY CONSTRAINTS 1999 ·PubMed ·Darin Taverna, (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact